Agoracom: Small Cap Investment - Stem Cell Therapeutics

AGORACOM News Flash

AGORACOM WIRE - FRIDAY MAY 25TH, 2012

FOCUS METALS (TSXV:FMS) Changes Its Name to Focus Graphite Inc.

Aim to develop and manufacture the best technology graphite in the world
Additional shareholder value will come from investment in commercialized graphene through joint venture partner, Grafoid Inc.

Read More | *SPONSOR

INTERNATIONAL PBX VENTURES (TSX:PBX) Signs Copaquire Joint Venture Option Agreement - $90M Potential Payment Read More

AGORACOM Maintenance Alert: Friday Evening Downtime for About an Hour Read More

LOMIKO METALS (TSXV:LMR) Graphite and Zinc Price Outlook is Favourable Through 2013 Read More | *SPONSOR

Message Title	Rating	Author / Date
Stem Cell Therapeutics Corp. Announces the Issuance of United States Patent Rela		CAFEGRAINS May 18, 11 07:13PM
Halted		CAFEGRAINS Mar 18, 11 10:02AM
STEM CELL THERAPEUTICS CORP. ANNOUNCES OUTCOME OF END OF PHASE II MEETING WITH F		CAFEGRAINS Dec 22, 10 10:40PM
NR: SSS Announces the Issuance of United States Patent Relating to NTx(R)-265		Moneytospend Dec 08, 10 03:31PM
NR: Executive Changes at Stem Cell Therapeutics Corp.		Moneytospend Nov 30, 10 06:18PM
NR: Stem Cell Therapeutics Corp. Announces Q3 2010 Financial Results		Moneytospend Nov 22, 10 02:00PM
NR: Stem Cell Announces Filing of Preliminary Short Form Base Shelf Prospectus		Moneytospend Nov 10, 10 10:18PM
NR: Stem Cell Therapeutics Corp. Announces Proceeds From Execution of Warrants	1	Moneytospend Nov 02, 10 07:48PM
NR: Stem Cell Therapeutics Corp. Announces Issuance of Stock Options		Moneytospend Oct 25, 10 11:50AM
Stem Cell Therapeutics Corp. Receives Request for Full TBI Proposal From the US		CAFEGRAINS Oct 12, 10 04:52PM
NR: Stem Cell Therapeutics Receives FDA End of Phase II Meeting Date		Moneytospend Oct 08, 10 03:41PM
NR: Stem Cell Therapeutics Corp. Announces Appointment of Chief Financial Office		Moneytospend Oct 01, 10 09:18AM
NR: SSS announces resignation of a BoD		Moneytospend Sep 15, 10 01:15PM
NR: SSS announces completion of further analysis etc.		Moneytospend Sep 09, 10 02:05PM
Stem Cell funds brain injury study, stock rises 27 percent		CAFEGRAINS Aug 30, 10 01:27PM
Level 11 Today		bubba9 Jun 28, 10 07:13PM
Halted		CAFEGRAINS Jun 24, 10 09:10AM
NR: SSS in the process of conducting a review of the full trial.......	1	Moneytospend Jun 17, 10 10:43AM
Re: NR: Stem Cell Therapeutics Corp. Announces the Issuance of United States Patent		bubba9 Jun 10, 10 12:36AM
Re: NR: Stem Cell Therapeutics Corp. Announces the Issuance of United States Patent	1	Digger69 Jun 09, 10 02:11PM
Re: NR: Stem Cell Therapeutics Corp. Announces the Issuance of United States Patent		bubba9 Jun 09, 10 11:39AM
Re: NR: Stem Cell Therapeutics Corp. Announces the Issuance of United States Patent		Digger69 Jun 08, 10 11:59PM
NR: Stem Cell Therapeutics Corp. Announces the Issuance of United States Patent	1	Moneytospend Jun 08, 10 02:56PM
Here's the link to Cantech Letter article	1	cantech Jun 05, 10 12:18AM
Mentions SSS	1	Moneytospend Jun 03, 10 01:12PM
Re: Wuzzup		Digger69 May 29, 10 08:25PM
Re: Wuzzup	3	BarbuBeatnik May 23, 10 01:59PM
Wuzzup		bubba9 May 23, 10 12:47AM
Very positive NR today	2	richpickins Apr 26, 10 06:35PM
SCT Announces Extension of Exipiring Date for Outstanding Warrants		Digger69 Apr 16, 10 10:38PM
SCT Announces Year End 2009 Financial Results		Digger69 Apr 14, 10 10:00AM
NR: Stem Cell announces Dr. Alan Moore's presentation	1	Moneytospend Apr 06, 10 12:56PM
NR: Stem Cell announces completion of enrollment in key..........	1	Moneytospend Mar 31, 10 07:18PM
Stem Cell Therapeutics Corp. Announces Presentations at the American Stroke Asso	1	Digger69 Feb 24, 10 09:49AM
NR: SSS provides update	1	Moneytospend Feb 16, 10 03:23PM
NEWS OUT 3rd & Final Positive DSMB Review	2	Digger69 Feb 09, 10 09:27AM
Re: SSS.V Will Be $1 Soon		Digger69 Feb 08, 10 08:08PM
TBI - Reviewed by NeuroInvestment	2	brutus2005 Feb 03, 10 06:52PM
Re: SSS.V Will Be $1 Soon		brutus2005 Jan 27, 10 01:20PM
Re: SSS.V Will Be $1 Soon		Digger69 Jan 24, 10 07:56PM

Message Title

Rating

Author / Date

Stem Cell Therapeutics Corp. Announces the Issuance of United States Patent Rela

CAFEGRAINS

May 18, 11 07:13PM

Halted

CAFEGRAINS

Mar 18, 11 10:02AM

STEM CELL THERAPEUTICS CORP. ANNOUNCES OUTCOME OF END OF PHASE II MEETING WITH F

CAFEGRAINS

Dec 22, 10 10:40PM